Bliss GVS Pharma Approves Financial Results, Recommends Dividend of 1 Rupee Per Share
Bliss GVS Pharma Limited announced the outcomes of its Board Meeting held on Tuesday, May 12, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.The company also recommended a final dividend of 100%, equivalent to 1 Rupee per equity share, on the face value of Rs. 1/each for the financial year ended March 31, 2026, which remains subject to shareholder approval at the forthcoming 41st Annual General Meeting (AGM).
Financial Results for FY2026
The Board approved the audited Standalone and Consolidated Financial Results for the year ended March 31, 2026. The company also received an unmodified opinion on these results from its statutory auditors.Key financial metrics for the year ended March 31, 2026, show the following totals:
| Metric | Standalone (₹ in Lakh) | Consolidated (₹ in Lakh) |
|---|---|---|
| Total Revenue | 1,435.51 | 2,344.05 |
| Net Profit for the Period | 9,687.44 | 13,412.11 |
| Total Equity | 115,518.52 | 123,175.93 |
| Total Liabilities | 18,899.12 | 20,943.94 |
The company’s balance sheet as of March 31, 2026, reflects total assets of 1,34,417.14 and total equity of 1,15,518.52.
Board Decisions and Corporate Governance Updates
During the meeting on May 12, 2026, the Board of Directors also took several governance decisions:1. Dividend Recommendation: A final dividend of 100%, or 1 Rupee per equity share, was recommended for the financial year ended March 31, 2026.
2. Internal Auditor: The Board recommended the re-appointment of M/s. BDO India Services Private Limited to serve as the Internal Auditor of the Company for the financial year 2026-27.
3. AGM Scheduling: The 41st Annual General Meeting (AGM) for the financial year ended March 31, 2026, is scheduled for Wednesday, July 15, 2026, at 11:00 A.M.
The company confirmed that the audited Standalone and Consolidated financial results are prepared in accordance with the recognition and measurement principles of Indian Accounting Standards (Ind AS).
Additional Information
The company also provided a brief profile of the internal auditor, BDO India Services Private Limited, and confirmed the appointment date for Mr. Hiren Upadhyay, Partner & Leader West, Business Advisory Services, for the financial year 2026-2027.BLISSGVS Stock Price Movement
On Tuesday, Bliss GVS Pharma Limited shares edged higher, gaining 1.41% to close at ₹273.8. The stock attracted significant trading volume, while the equity also touched its 52-week high of ₹284.5.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.